Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Qlucore Yönetim

Yönetim kriter kontrolleri 2/4

Qlucore's CEO'su Carl-Johan Ivarsson, Jan2007 tarihinde atandı, in görev süresi 17.75 yıldır. şirketin hisselerinin 8.6% doğrudan sahiptir ve bu hisselerin değeri SEK 2.01M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 10.2 yıl ve 5.8 yıldır.

Anahtar bilgiler

Carl-Johan Ivarsson

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	17.8yrs
CEO sahipliği	8.6%
Yönetim ortalama görev süresi	10.2yrs
Yönetim Kurulu ortalama görev süresi	5.8yrs

Son yönetim güncellemeleri

Recent updates

CEO

Carl-Johan Ivarsson

17.8yrs

Görev süresi

Mr. Carl-Johan Ivarsson is Co-Founder, CEO & Director of Qlucore Ab (Publ) since 2007 and also serves as its Chair of Scientific Advisory Board since January 2022. Mr. Ivarsson has a master's degree in ele...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Carl-Johan Ivarsson	Chair of Scientific Advisory Board	17.8yrs	Veri yok	8.6% SEK 1.9m
Thoas Fioretos	Co-Founder	17.8yrs	Veri yok	4.58% SEK 1.0m
Johan Rade	Co-Founder	17.8yrs	Veri yok	8.35% SEK 1.9m
Magnus Fontes	Member of Scientific Advisory Board	no data	Veri yok	4.63% SEK 1.0m
Cecilia Grotte	Chief Financial Officer	2.7yrs	Veri yok	Veri yok
Ulf Ahlfors	Head of Research & Development	2.7yrs	Veri yok	Veri yok
Erik Soderback	Head of Diagnostics Sales	2.5yrs	Veri yok	Veri yok

10.2yrs

Ortalama Görev Süresi

Deneyimli Yönetim: QCORE 'un yönetim ekibi deneyimli ve deneyimlidir ( 10.2 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Carl-Johan Ivarsson	Chair of Scientific Advisory Board	17.8yrs	Veri yok	8.6% SEK 1.9m
Thoas Fioretos	Co-Founder	17.8yrs	Veri yok	4.58% SEK 1.0m
Magnus Fontes	Member of Scientific Advisory Board	17.8yrs	Veri yok	4.63% SEK 1.0m
Lars Hockenstrom	Independent Director	1.1yrs	Veri yok	Veri yok
Pia Magrhild Gideon	Independent Chairman	15.8yrs	Veri yok	Veri yok
Boel Sundvall	Independent Director	5.8yrs	Veri yok	Veri yok
Helle Fisker	Independent Director	2.7yrs	Veri yok	Veri yok
Albrecht Stenzinger	Member of Scientific Advisory Board	2.8yrs	Veri yok	Veri yok
Aurelien de Reynies	Member of Scientific Advisory Board	2.8yrs	Veri yok	Veri yok
Solange Peters	Member Scientific Advisory Board	no data	Veri yok	Veri yok

5.8yrs

Ortalama Görev Süresi

63.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: QCORE 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.8 yıldır).

Qlucore Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Qlucore AB (publ), Annual General Meeting, Sep 09, 2024

Less than half of directors are independent

Qlucore AB (Publ) Appoints Lars Höckenström as A Member of the Board of Directors

Qlucore Names Erik Söderbäck as Head of Diagnostics Sales

Qlucore AB (Publ) Appoints Helle Fisker as Regular Member of the Board

Qlucore Appoints Ulf Ahlfors as Head of R&D

Recent updates

New major risk - Financial position

First quarter 2025 earnings released: kr1.87 loss per share (vs kr1.24 loss in 1Q 2024)

Qlucore AB (publ) to Report Q1, 2025 Results on Aug 29, 2024

Full year 2024 earnings released: kr3.89 loss per share (vs kr3.96 loss in FY 2023)

Qlucore Starts Project After Receiving EU Grant to Advance Personalized Cancer Treatment

Third quarter 2024 earnings released: kr0.69 loss per share (vs kr0.72 loss in 3Q 2023)

Qlucore Diagnostics for Pediatric Leukemia Takes A Significant Step Closer to Ce Marking

Qlucore Announces Swedish Innovation Evaluated for Clinical Diagnosis of Pediatric Leukemia

Qlucore AB (publ), Annual General Meeting, Sep 09, 2024

Second quarter 2024 earnings released: kr0.81 loss per share (vs kr1.03 loss in 2Q 2023)

Less than half of directors are independent

Qlucore AB (Publ) Appoints Lars Höckenström as A Member of the Board of Directors

First quarter 2024 earnings released: kr1.24 loss per share (vs kr1.20 loss in 1Q 2023)

New minor risk - Share price stability

Full year 2023 earnings released: kr3.96 loss per share (vs kr2.90 loss in FY 2022)

Qlucore AB (publ) to Report Q1, 2024 Results on Aug 30, 2023

Third quarter 2023 earnings released: kr0.72 loss per share (vs kr0.10 profit in 3Q 2022)

Second quarter 2023 earnings released: kr1.03 loss per share (vs kr1.62 loss in 2Q 2022)

Qlucore AB (publ) to Report First Half, 2023 Results on Nov 28, 2022

Qlucore Software Used in New Project to Prevent Cardiovascular Diseases

Qlucore Receives Patent in Europe

First quarter 2023 earnings released

Qlucore Expands Its Leukemia Diagnostics Solution

Qlucore Ab (Publ) to Report Q1, 2023 Results on Aug 30, 2022

Full year 2022 earnings released

Qlucore Names Erik Söderbäck as Head of Diagnostics Sales

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Qlucore AB (Publ) Appoints Helle Fisker as Regular Member of the Board

Qlucore Appoints Ulf Ahlfors as Head of R&D

Qlucore Announces Management Changes

Qlucore AB (publ) Announces Major New Release for Bioinformatics

CEO

Görev süresi

Liderlik Ekibi

Ortalama Görev Süresi

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş